The response of plasma
Abstract
Gastric inhibitory polypeptide (GIP) is known to enhance insulin secretion induced by glucose and, therefore, is considered to play an important role in the entero-insular axis. Crockett et al. (1976) and Ross et al. (1977) reported that plasma GIP response to oral glucose loading was exaggerated in diabetes mellitus. However, May and Williams (1978) failed to demonstrate the exaggerated GIP response in mild diabetic patients. Moreover, Reynolds et al. (1979) observed significantly diminished GIP response to glucose ingestion in insulin-dependent diabetics.
Because of such discordant results, we chose to compare plasma GIP responses to glucose ingestion in mild, moderate, and severe diabetic patients.
Materials
and Methods
Subjects
Ten normal volunteers aged 17 to 68, 5 males and 5 females, who had no family history of diabetes were studied. Twenty patients with primary diabetes mellitus were diagnosed by means of the oral glucose tolerance test, excluding endocrine, liver and pancreatic diseases which might cause glucose intolerance. The criteria for diabetes proposed by the Japan Diabetes Association (Kuzuya, 1970) were used to evaluate the glucose tolerance curve: patients with blood glucose concentrations exceeding 160 mg/dl at 60 min and 130 mg/d/ at 120 min after oral administration of 50 g glucose are defined as diabetics those with blood glucose concentrations below 100 mg/dl at 0 min, 140 mg/d/ at 60 min, and 100 mg/d/ at 120 min are defined as normal. Ten diabetic patients, aged 30 to 71, 7 males and 3 females, with fasting blood glucose levels less than 140 mg/d/ and with glucose tolerance curves typical of diabetes were de- 
Results
Normal subjects (Fig. 2) : Blood glucose concentrations rose from the mean basal level of 87 •} 3 mg/dl to the mean peak value of 131 •} 6 mg/dl 30 min after oral glucose loading.
The mean basal plasma insulin concentration was 8.7 •} 2.3 which increased significantly, reaching a peak 30 min after glucose administration. The plasma GIP level rose promptly after oral glucose loading, reaching the peak value of 513 •} 44 pg/mi at 30 min, which was significantly higher than the mean Mild diabetes (Fig. 3) : In mild diabetic patients, oral glucose loading caused an abrupt rise in plasma GIP from the basal concentration of 238•}33 pg/m/ (P > 0.05 vs. normal subjects) to the peak value of 683•}71 pg/m/ occurring at 30 min. The mean peak GIP was significantly higher than the corresponding value in normal subjects (p < 0.05). The mean peak plasma insulin concentration induced by glucose Fig. 3 glucose loading elicited no significant response of plasma insulin. The mean fasting GIP level was 304 •} 31 pg/m/, which was significantly higher than that in normal subjects (p< 0.01). Glucose ingestion caused a greater rise in plasma GIP than in normal subjects. The mean peak plasma GIP in these patients occurred 30 min after glucose ingestion and was 870•}63 pg/m/, which was significantly higher than that in normal subjects (p < 0.01). Crockett et al. (1976) and Ross et al. (1977) have demonstrated that plasma GIP response to oral glucose loading is exaggerated in untreated diabetic patients. The present study confirms these observations and further demonstrates that plasma GIP response to glucose ingestion is enhanced even in mild diabetes. May and Williams (1978) , however, reported no enhancement of GIP response to oral glucose loading in mild diabetes when compared with normal subjects. The reason for this discrepancy is not clear, but differences in blood glucose and plasma insulin levels during oral glucose loading may be important; the diabetic subjects studied by May and Williams (1978) had milder glucose intolerance and more circulating insulin.
Discussion
The mechanism responsible for the exaggerated GIP response to glucose ingestion, though not clear at present, deserves consideration.
Recent studies (Brown et al., 1975; Crockett et al., 1976; Ross et al., 1977) have suggested that the augmented GIP release to glucose ingestion in diabetics may be the result of attenuated insulin secretion.
In the present study we have observed that plasma insulin response to glucose is significantly impaired in moderateto severe diabetics, and even in mild diabetics insulin release is delayed and inappropriate for the amount of circulating glucose. Therefore, our findings that GIP response to oral glucose loading is increased in proportion to the severity of impaired insulin secretion lend support to this hypothesis. The effect of insulin on GIP secretion, however, is still controversial and inconclusive. Creutzfeldt et al. (1980) have demonstrated that the infusion of insulin alone or together with glucose significantly suppresses the GIP rise after fat ingestion, but does not alter the GIP response to oral glucose in juvenile diabetes. On the other hand, Sirinek et al. (1978) reported that insulin is capable of attenuating the GIP response to glucose in a negative feedback fashion in dogs. The final answer must await further studies on this problem. Recently, Reynolds et al. (1979) have reported that there is a significantly lower response of GIP secretion to oral glucose loading in insulin-dependent diabetics than in normal subjects. This contrasts with the results of our present study. But our diabetic subjects were untreated, and findings seen in well established diabetes are not necessarily characteristic of the early stages of the disease.
We conclude, therefore, that impaired insulin secretion accompanied by hyperglycemia probably, at least in part, contributes to the hypersecretion of GIP in diabetic patients.
